Bonerge Lifesience is excited to announce the launch of its new branded ingredient, GlucoVest, designed to support blood sugar and lipid metabolism as well as weight management. As Berberine and its so-called “natural Ozempic” gain viral popularity on TikTok, many supplement brands incorporate Berberine into their products. To meet the increasing demand for higher quality products, Bonerge introduces GlucoVest, a superior Dihydroberberine ingredient, offering a new option for supplement brands.
Dihydroberberine, GlucoVest’s active component, is a Berberine derivative with similar benefits. Importantly, Dihydroberberine has better bioavailability than Berberine. Unlike Berberine, which has been reported to cause side effects such as vomiting, Dihydroberberine has no report of adverse effects in published toxicology studies.
Berberine’s surge in popularity is due to its weight loss mechanism similar to Semaglutide’s. As both of them can boost the secretion of GLP-1. GLP-1 increases satiety, reduces food intake, enhances energy expenditure, and delays gastric emptying time. Besides its weight loss effects, research indicates that Berberine can improve insulin sensitivity, reduce blood sugar levels, and enhance lipid metabolism by promoting the conversion of white fat to brown fat and lowering plasma LDL cholesterol, free fatty acids, and total cholesterol levels.
Through extensive research and development, GlucoVest is produced with a unique manufacturing procedure that yields high-quality crystalline Dihydroberberine. Even the granulated specifications, can maintain a high assay level compared to other Dihydroberberine on the market while maintaining the flowability of powder. This allows for maximizing the efficacy of Dihydroberberine and providing brands with more versatile product applications.
